Patent details

LUC00086 Product Name: "Brexpiprazole ou un sel de celui-ci"

Basic Information

Publication number:
LUC00086
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP067320697
Legal Status:
Active
Application number:
LUC00086
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1294
Marketing Authorization Type:
Marketing Authorization Date:
30/07/2018
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
14/09/2018
First Marketing Authorization date:
30/07/2018
Grant date:
26/11/2018
Activation date:
12/04/2026
Publication date:
20/09/2018
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
12/04/2031
SPC Extension Expiration:
12/04/2031
Rejection date:
Withdrawal date:

Owner

From:
14/09/2018
 
 

Name:
OTSUKA PHARMACEUTICAL CO. LTD.
Address:
9, Kanda-Tsukasacho 2-chome, Chiyoda-ku, Tokyo 101-8535, Japan (JP)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
14/09/2018
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2018/11
Publication date:
11/10/2018
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2018/13
Publication date:
13/12/2018
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
30/04/2027
Annual Fee Number:
22
Annual Fee Amount:
420 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/03/2026
Last Annual Fee Paid Number:
21
Last Annual Fee Paid Amount:
410 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
14/09/2018 General Document 52
14/09/2018 Application Form 4
20/09/2018 Outgoing Correspondence 1
26/11/2018 Certificate 1
14/09/2018 General Document 4
20/09/2018 Publication 1
26/11/2018 Publication 1
14/09/2018 General Document 3